Cargando…
PPARs modulate cardiac metabolism and mitochondrial function in diabetes
Diabetic cardiomyopathy is a major complication of diabetes mellitus (DM). Currently, effective treatments for diabetic cardiomyopathy are limited. The pathophysiology of diabetic cardiomyopathy is complex, whereas mitochondrial dysfunction plays a vital role in the genesis of diabetic cardiomyopath...
Autores principales: | Lee, Ting-Wei, Bai, Kuan-Jen, Lee, Ting-I, Chao, Tze-Fan, Kao, Yu-Hsun, Chen, Yi-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223385/ https://www.ncbi.nlm.nih.gov/pubmed/28069019 http://dx.doi.org/10.1186/s12929-016-0309-5 |
Ejemplares similares
-
HDAC Inhibition Modulates Cardiac PPARs and Fatty Acid Metabolism in Diabetic Cardiomyopathy
por: Lee, Ting-I, et al.
Publicado: (2016) -
Empagliflozin and Liraglutide Differentially Modulate Cardiac Metabolism in Diabetic Cardiomyopathy in Rats
por: Trang, Nguyen Ngoc, et al.
Publicado: (2021) -
Sodium hydrosulphide restores tumour necrosis factor‐α‐induced mitochondrial dysfunction and metabolic dysregulation in HL‐1 cells
por: Lee, Ting‐I, et al.
Publicado: (2019) -
Spike Protein Impairs Mitochondrial Function in Human Cardiomyocytes: Mechanisms Underlying Cardiac Injury in COVID-19
por: Huynh, Tin Van, et al.
Publicado: (2023) -
Sugar Fructose Triggers Gut Dysbiosis and Metabolic Inflammation with Cardiac Arrhythmogenesis
por: Cheng, Wan-Li, et al.
Publicado: (2021)